電気生理市場：製品別（ラボデバイス（3Dマッピング、レコーディング）、アブレーションカテーテル（Cryoablation、RF）、診断用カテーテル（従来型、先進型、超音波））、適応症（AF、AVNRT、WPW）、エンドユーザー（病院、ASC） - 2027年までの世界市場予測

Electrophysiology Market by Product (Lab Devices (3D Mapping, Recording), Ablation Catheters (Cryoablation, RF), Diagnostic Catheters (Conventional, Advanced, Ultrasound)), Indication (AF, AVNRT, WPW), End User (Hospitals, ASCs) - Global Forecasts to 2027

電気生理の世界市場は、2022年から2027年の予測期間中にCAGR9.4%で、2021年の68億米ドルから2027年には116億米ドルに達すると予測されます。電気生理学（EP）検査は、複雑な心疾患を診断・治療するために、患... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2022年3月2日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	284	224	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

電気生理の世界市場は、2022年から2027年の予測期間中にCAGR9.4%で、2021年の68億米ドルから2027年には116億米ドルに達すると予測されます。

電気生理学（EP）検査は、複雑な心疾患を診断・治療するために、患者の心臓の電気的活動や電気経路を調べるために実施されます。これにより、電気生理学者は心調律障害の原因を理解し、必要な治療法を提案することができます。電気生理学（EP）とは、心臓の電気的活動を分析・診断するために研究される心臓の電気システムのことである。心臓電気生理学では、侵襲的なカテーテルを用いて心臓の電気活動を記録し、その現象を研究する。この研究は、複雑な不整脈や心拍障害を評価するのに役立ちます。

電気生理学の世界市場の成長は、技術の進歩、市場への新規参入、投資、資金、助成金の増加、対象疾患や処置の発生率の増加などの要因によるものと思われます。また、新興国市場は、この市場で活動するプレーヤーに高い成長機会を提供すると期待されています。

WHOによると、CVDは世界における死因の第1位です。CVDや脳卒中の有病率上昇の主な要因としては、家族歴、民族性、年齢などが挙げられます。米国心臓協会によると、2030年までに米国成人の約41.4％が高血圧症になるとされています（2012年から8.4％の増加）。また、同団体は、CVDの世界的なコストは、2010年の8630億米ドルから2030年には1兆440億米ドルに達すると推定しています。2016年には、世界で〜1790万人がCVDで死亡しています。2030年には、この数は2,360万人に増加すると推定されています（出典：WHO）。

心房細動は、臨床現場で診断される最も一般的な不整脈であり、ヨーロッパでは毎年新たに88万6,000人以上が罹患しています。2030年には、心房細動の患者数は人口の70％まで増加すると予想されており、2050年には、ヨーロッパが最も心房細動の患者数が多くなると予想されています（出典：2018年心房細動の負担に関する報告書）。米国では、2012年に約270万人から610万人がAFの影響を受けましたが、2030年には1210万人に増加すると推定されています（出典：CDC）。2015年8月にMedical Journal of Australiaに掲載された研究によると、オーストラリアにおける55歳以上のAF患者数は2014年6月に328,562人であり、2034年には60万人以上に達すると推定されています。これらの疾患の発生率の上昇は、それに対応してEP処置の需要を促進し、電気生理学市場の主要な成長ドライバーとなります。例えば、世界のアブレーション施術数は2017年の973,220件から2022年には年間1,455,000件に増加すると予測されており、この中で複合アブレーション（AFおよびVT）は2017年の440,629件から2022年の830,390件へと毎年13%増加すると見込まれています（出典：バイオシグテクノロジー、年次報告、2019年）。

しかしながら、電気生理製品の高コスト、不適切な償還、米国における不利な医療改革、新製品上市のためのコスト高な臨床データの要求、代替技術の利用可能性などの要因が、今後数年間、この市場の成長を抑制すると予想されています。また、機器の再使用や再処理、熟練した電気生理専門医の不足なども、同市場の課題として挙げられます。また、COVID-19の大流行により、予測期間中に市場の成長が一時的に鈍化することが予想されます。

"2021年の電気生理検査装置部門が世界の電気生理検査市場で最大のシェアを占める"

電気生理の世界市場は、製品別にEP診断カテーテル、EPアブレーションカテーテル、EPラボラトリーデバイス、アクセスデバイス、その他の製品に大別される。

電気生理検査装置市場は、3Dマッピングシステム、電気生理検査記録システム、RFアブレーションシステム、心内エコー（ICE）超音波イメージングシステム、電気生理検査X線システム、その他の電気生理検査装置（MRIシステム、電気生理検査遠隔磁気・ロボットナビゲーションシステム）に区分されます。
2021年の電気生理学市場では、EPラボ機器分野が57.0％の最大シェアを占めた。このセグメントは、予測期間中にCAGR 10.6%で成長すると予測される。

このセグメントの大きなシェアは、技術的に高度な3Dマッピングシステムの発売に対する市場プレイヤーの注目度の高まり、新しい電気生理記録システムの開発に対する官民の資金提供の増加、RFアブレーション施術数の増加、他のアブレーション技術と比較したRFアブレーション施術の費用対効果、主要市場におけるこれらの製品の入手可能性の高まりに起因するものと考えられます。

"2021年のエンドユーザー別電気生理市場において、病院・心臓センター部門が最大の市場シェアを占める"

エンドユーザーセグメントに基づき、電気生理学市場は病院＆心臓センターと外来手術センターに区分されます。2021年の市場シェアは、病院＆心臓センター部門が最大（92.53％）です。このエンドユーザーセグメントの大きなシェアは、主に病院内の大きなカトラボや電気生理ラボの存在、CVDの有病率の上昇、アブレーション施術数の増加などに起因しているものと思われます。

病院・心臓センター部門には、政府病院と民間病院の両方、および心臓疾患患者の治療を行う心臓センターが含まれます。電気生理学的処置のほとんどは、病院や心臓病センターの電気生理学（EP）ラボやカテーテルラボで実施されます。心臓疾患の患者に治療を提供する心臓センターの数は、世界中で急速に増加しています。例えば、2016年6月には、ヘルスサイエンスノース（カナダ）とグレーターサドベリー（カナダ）の循環器専門医のチームが協力し、心臓治療のための新しいワンストップセンターを立ち上げました。2016年10月には、米国のKare Partners Groupがインドのチャンディーガルで心臓専門治療センターを立ち上げました。こうした立ち上げは、電気生理学的機器の需要を促進することが期待されます。

"2021年の適応症タイプ別電気生理検査市場において、心房細動分野が最大のシェアを占める"

電気生理市場は、適応症の種類に基づいて、心房細動、房室結節性リエントリー頻拍（AVNRT）、ウォルフ・パーキンソン-ホワイト（WPW）症候群、心房粗動、その他の適応症に区分されます。心房細動の有病率の増加、心房細動に関連するアブレーション手術の増加、世界的な高齢化社会の急速な進展、心房細動の早期診断のための高度電気生理製品の開発などにより、今後、この市場セグメントの成長が期待されます。

2021年の電気生理学市場の適応症別では、心房細動市場が最大のシェアを占めています。心房粗動分野は、2021年の電気生理学世界市場において2番目に大きなシェアを占めると予測されます。

米国では、2019年に約530万人が心房細動を患っていると報告されています（出典：米国心臓協会）。2050年には、米国で約1,200万人が心房細動に罹患すると予想されています。欧州心臓病学会（ESC）の機関誌「EP Europace」に掲載された論文によると、EU地域の65歳以上の約760万人が2016年に心房細動を発症し、2060年には89％増の1440万人になるという。このような心房細動の有病率の増加により、心房細動アブレーションの実施件数が大幅に増加することが予想されます。

AFibの有病率の増加を受けて、多くの主要企業が抗不整脈薬（AAD）に対するカテーテルアブレーションの優位性をアピールするための研究を進めています。例えば、2019年11月、バイオセンスウェブスターは新しい心房細動管理レポートを発表し、カテーテルアブレーションが薬物療法よりも心房細動の進行を遅らせる効果がほぼ10倍あることを強調している。

"地域別ではAPAC市場が予測期間中に最も高い成長率を記録する"

電気生理市場は、地域別に北米、欧州、アジア太平洋地域、中南米、中東・アフリカに区分されます。アジア太平洋地域は、予測期間中に最も高い成長を記録すると予想されます。アジア太平洋地域は、中国、インド、日本、韓国、オーストラリア、およびマレーシア、台湾、シンガポール、ニュージーランドなどのその他のアジア太平洋地域に区分されます。

中国とインドが最も高い成長率を占めると予想されます。これらの国では、ライフスタイルや食習慣の変化、ストレスの増加、喫煙や飲酒の習慣化などにより、肥満、心臓病、その他の慢性疾患など、健康に関連する問題が増加しています。また、人口の多さ、老年人口の増加、慢性疾患の増加、医療費の増加、インフラ整備のための医療改革、先端技術に対する需要の増加、有力企業による新興市場への注力の高まり、規制の緩さなどの要因も、この地域の電気生理機器の需要を促進しています。

しかし、先進的な製品の価格が高いこと、最新の心臓再同期技術に対応するためのインフラ整備が不十分であること、健康関連問題への意識が低いことなどが、この市場の成長を阻害すると予想されています。また、この地域のエンドユーザーの多くは予算が限られており、低価格の製品を選んでいることも、市場成長を阻む大きな要因となっています。

本レポートで参照した主な参加企業の内訳は以下のとおりです。
- 企業タイプ別ティア1～25％、ティア2～37％、ティア3～38％。
- 役職別Cレベル-34%、ディレクターレベル-35%、その他-31
- 地域別北米24％、欧州32％、アジア太平洋28％、中南米10％、中近東・アフリカ6

電気生理市場の有力企業には、アボット社（米国）、メドトロニック社（アイルランド）、ボストン・サイエンティフィック社（米国）、Koninklijke Philips N.V. （オランダ）、GEヘルスケア社（米国）、Siemens Healthcare GmbH（ドイツ）、Stereotaxis, Inc.社があります。(米国）、Merit Medical Systems（米国）、Atricure Inc.(米国）、APN Health, LLC（米国）、Osypka Medical（ドイツ）、日本ライフライン株式会社（米国）、Stereotaxis, Inc.(日本）、Johnson & Johnson（米国）、Biotronik（ドイツ）、MicroPort Scientific Corporation（中国）、Acutus Medical, Inc.（米国）。(米国)があります。

研究対象

本レポートでは、電気生理市場を製品タイプ、適応症タイプ、エンドユーザー、地域に基づいて調査しています。また、市場成長に影響を与える要因を取り上げ、市場における様々な機会や課題を分析し、市場リーダー向けの競争環境についても詳しく解説しています。さらに、個々の成長動向に関してマイクロマーケットを分析し、主要5地域（およびこれらの地域のそれぞれの国）に関して市場セグメントの収益を予測しています。
レポート購入の理由
本レポートは、既存企業だけでなく、新規参入企業や中小企業も市場の動向を把握することができ、ひいてはより大きな市場シェアを獲得するのに役立つものと思われます。本レポートを購入された企業は、以下の戦略の1つまたは複数を組み合わせて、市場での存在感を高めることができます。

本レポートでは、以下のポイントについて考察しています。
市場の浸透。電気生理学市場のトッププレイヤーが提供する製品ポートフォリオに関する包括的な情報
製品開発/イノベーション。電気生理市場における今後の動向、研究開発活動、製品の上市に関する詳細な洞察
市場開拓。有利な新興国地域に関する包括的な情報
市場の多様化。新製品、成長地域、電気生理学市場の最近の動向に関する詳細な情報
競争力のある評価。市場セグメント、成長戦略、収益分析、主要な市場プレイヤーの製品に関する詳細な評価。

ページTOPに戻る

1 INTRODUCTION 31
1.1 OBJECTIVES OF THE STUDY 31
1.2 MARKET DEFINITION 32
1.2.1 INCLUSIONS AND EXCLUSIONS 32
1.3 MARKET SCOPE 33
1.3.1 MARKETS COVERED 33
1.3.2 YEARS CONSIDERED 34
1.4 CURRENCY USED 34
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 34
1.5 KEY MARKET STAKEHOLDERS 35
1.6 SUMMARY OF CHANGES 35
2 RESEARCH METHODOLOGY 37
2.1 RESEARCH DATA 37
FIGURE 1 RESEARCH DESIGN 37
2.1.1 SECONDARY DATA 38
2.1.1.1 Key data from secondary sources 38
2.1.1.2 Indicative list of secondary sources 40
2.1.2 PRIMARY DATA 41
2.1.2.1 Breakdown of primaries 41
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 41
2.2 MARKET ESTIMATION METHODOLOGY 42
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 42
2.2.1 VENDOR REVENUE-BASED MARKET ESTIMATION 43
FIGURE 4 MARKET SIZE ESTIMATION: VENDOR REVENUE-BASED MARKET ESTIMATION 44
2.2.2 END USER-BASED MARKET ESTIMATION 44
FIGURE 5 MARKET SIZE ESTIMATION: END USER-BASED MARKET ESTIMATION 44
2.2.3 PRIMARY RESEARCH VALIDATION 45
2.3 DATA TRIANGULATION METHODOLOGY 45
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 45
FIGURE 6 DATA TRIANGULATION METHODOLOGY 46
2.5 RESEARCH ASSUMPTIONS 47
2.6 RESEARCH LIMITATIONS 47

3 EXECUTIVE SUMMARY 48
FIGURE 7 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021 VS. 2027 (USD MILLION) 48
FIGURE 8 ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2021 VS. 2027 (USD MILLION) 49
FIGURE 9 ELECTROPHYSIOLOGY MARKET, BY END USER,
2021 VS. 2027 (USD MILLION) 50
FIGURE 10 ASIA PACIFIC MARKET TO HAVE HIGHEST CAGR DURING
FORECAST PERIOD (2022-2027) 51
4 PREMIUM INSIGHTS 52
4.1 ELECTROPHYSIOLOGY MARKET OVERVIEW 52
FIGURE 11 TECHNOLOGICAL ADVANCEMENTS TO DRIVE GLOBAL ELECTROPHYSIOLOGY MARKET GROWTH 52
4.2 GEOGRAPHIC ANALYSIS: ELECTROPHYSIOLOGY MARKET, BY INDICATION AND REGION 53
FIGURE 12 ATRIAL FIBRILLATION SEGMENT DOMINATED ELECTROPHYSIOLOGY MARKET IN 2021 BY INDICATION 53
4.3 GEOGRAPHIC ANALYSIS: ELECTROPHYSIOLOGY MARKET, BY PRODUCT AND INDICATION 54
FIGURE 13 ELECTROPHYSIOLOGY LABORATORY DEVICES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021 IN PRODUCT SEGMENT 54
4.4 ELECTROPHYSIOLOGY MARKET SHARE, BY END USER, 2021 VS. 2027 55
FIGURE 14 HOSPITALS & CARDIAC CENTERS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 55
FIGURE 15 BY END USER 2021 VS 2027 55
4.5 GEOGRAPHICAL SNAPSHOT OF ELECTROPHYSIOLOGY MARKET 56
FIGURE 16 CHINA TO REGISTER HIGHEST CAGR DURING
FORECAST PERIOD (2022-2027) 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
FIGURE 17 ELECTROPHYSIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57
5.2.1 DRIVERS 57
5.2.1.1 High rate of technological advancements 57
5.2.1.1.1 Increased use of non-invasive cardiac mapping 58
5.2.1.1.2 Increased use of improved intracardiac ablation systems 58
5.2.1.1.3 Increased use of MRI guided ablation procedures 59
5.2.1.1.4 Growing level of ultrasound guidance in the EP Lab 59
5.2.1.2 Rising number of new entrants in the market 59
TABLE 2 NEW ENTRANTS IN THE CARDIAC MAPPING SYSTEMS MARKET 60
5.2.1.3 Growing investments, funds, and grants for cardiac surgeries and electrophysiology 61
5.2.1.4 Increasing incidence of target diseases and procedures 61

5.2.2 RESTRAINTS 62
5.2.2.1 High cost of electrophysiology products and inadequate reimbursement process 62
5.2.2.2 Unfavorable healthcare reforms in the US 63
5.2.2.3 Cost-intensive requirement for clinical data for new product launches along with availability of alternative technologies 63
5.2.3 OPPORTUNITIES 64
5.2.3.1 Rising number of emerging markets 64
5.2.4 CHALLENGES 65
5.2.4.1 Increasing rate of reusing and reprocessing of devices 65
5.2.4.2 Lack of skilled and experienced electrophysiologists 65
5.3 REGULATORY LANDSCAPE 66
TABLE 3 INDICATIVE LIST OF REGULATORY AUTHORITIES 66
5.3.1 NORTH AMERICA 66
5.3.1.1 US 66
TABLE 4 CLASSIFICATION OF MEDICAL DEVICES BY US FDA 67
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 67
5.3.1.2 Canada 68
TABLE 6 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 68
5.3.2 EUROPE 68
5.3.3 ASIA PACIFIC 69
5.3.3.1 India 69
5.3.3.2 China 70
TABLE 7 CHINA (NPMA): CLASSIFICATION OF MEDICAL DEVICES 70
5.3.3.3 Japan 71
TABLE 8 CLASSIFICATION OF MEDICAL DEVICES BY PMDA 71
5.4 COVID-19 IMPACT 72
5.5 REIMBURSEMENT SCENARIO 73
TABLE 9 MEDICAL REIMBURSEMENT CODES FOR 2022 (PHYSICIAN) 74
TABLE 10 MEDICAL REIMBURSEMENT CODES FOR 2022 (HOSPITAL OUTPATIENT) 76
TABLE 11 MEDICAL REIMBURSEMENT CODES FOR 2022 (HOSPITAL INPATIENT) 77
5.6 PATENT ANALYSIS 78
5.6.1 PATENTS GRANTED FOR ELECTROPHYSIOLOGY 78
FIGURE 18 NUMBER OF PATENTS ISSUED (2011 -2021) 78
5.6.2 JURISDICTION AND TOP APPLICANT ANALYSIS 79
TABLE 12 TOP 10 PATENT OWNERS FOR ELECTROPHYSIOLOGY
(JANUARY 2011 TO DECEMBER 2021) 79
FIGURE 19 TOP 10 PATENTS OWNERS FOR ELECTROPHYSIOLOGY
(JANUARY 2011 TO DECEMBER 2021) 79
FIGURE 20 TOP 10 PATENT APPLICANTS FOR ELECTROPHYSIOLOGY
(JANUARY 2011 TO DECEMBER 2021) 80
FIGURE 21 PATENTS FOR ELECTROPHYSIOLOGY, BY JURISDICTION
(JANUARY 2011 TO DECEMBER 2021) 80

5.7 VALUE CHAIN ANALYSIS 81
FIGURE 22 VALUE CHAIN OF ELECTROPHYSIOLOGY MARKET 81
5.8 PRICING TREND ANALYSIS 82
TABLE 13 AVERAGE PRICE OF ELECTROPHYSIOLOGY PRODUCTS,
BY DEVICE NAME, 2020 (USD) 82
5.9 PORTER’S FIVE FORCES ANALYSIS 82
TABLE 14 ELECTROPHYSIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 82
5.9.1 THREAT OF NEW ENTRANTS 83
5.9.2 THREAT OF SUBSTITUTES 83
5.9.3 BARGAINING POWER OF SUPPLIERS 83
5.9.4 BARGAINING POWER OF BUYERS 83
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 83
5.10 ECOSYSTEM LANDSCAPE 84
FIGURE 23 ELECTROPHYSIOLOGY MARKET: ECOSYSTEM LANDSCAPE 84
6 ELECTROPHYSIOLOGY MARKET, BY PRODUCT 85
6.1 INTRODUCTION 86
TABLE 15 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 86
6.2 ELECTROPHYSIOLOGY LABORATORY DEVICES 86
TABLE 16 EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 87
TABLE 17 EP LABORATORY DEVICES MARKET, BY INDICATION,
2019–2027 (USD MILLION) 87
TABLE 18 EP LABORATORY DEVICES MARKET, BY END USER,
2019–2027 (USD MILLION) 88
TABLE 19 EP LABORATORY DEVICES MARKET, BY REGION, 2019–2027 (USD MILLION) 88
6.2.1 3D MAPPING SYSTEMS 88
6.2.1.1 Development of alternative technologies to hinder market growth 88
TABLE 20 3D MAPPING SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION) 89
6.2.2 ELECTROPHYSIOLOGY RECORDING SYSTEMS 90
6.2.2.1 Increasing public-private funding to drive market growth 90
TABLE 21 ELECTROPHYSIOLOGY RECORDING SYSTEMS MARKET,
BY REGION, 2019–2027 (USD MILLION) 90
6.2.3 RADIOFREQUENCY (RF) ABLATION SYSTEMS 91
6.2.3.1 Rising number of RF ablation procedures to drive market growth 91
TABLE 22 RF ABLATION SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION) 91
6.2.4 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) ULTRASOUND IMAGING SYSTEMS 92
6.2.4.1 Advantages of ICE ultrasound imaging systems to drive market growth 92
TABLE 23 ICE ULTRASOUND IMAGING SYSTEMS MARKET, BY REGION,
2019–2027 (USD MILLION) 92
6.2.5 ELECTROPHYSIOLOGY X-RAY SYSTEMS 93
6.2.5.1 Magnetic navigation systems to hamper market growth 93
TABLE 24 ELECTROPHYSIOLOGY X-RAY SYSTEMS MARKET, BY REGION,
2019–2027 (USD MILLION) 93
6.2.6 ELECTROPHYSIOLOGY REMOTE MAGNETIC AND
ROBOTIC NAVIGATION SYSTEMS 94
6.2.6.1 Favorable reimbursement scenario to drive market growth 94
TABLE 25 ELECTROPHYSIOLOGY REMOTE MAGNETIC AND ROBOTIC NAVIGATION SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION) 95
6.3 ELECTROPHYSIOLOGY ABLATION CATHETERS 95
TABLE 26 EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 95
TABLE 27 EP ABLATION CATHETERS MARKET, BY INDICATION,
2019–2027 (USD MILLION) 96
TABLE 28 EP ABLATION CATHETERS MARKET, BY END USER,
2019–2027 (USD MILLION) 96
TABLE 29 EP ABLATION CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION) 97
6.3.1 CRYOABLATION ELECTROPHYSIOLOGY CATHETERS 97
6.3.1.1 Significant therapeutic advantages to drive market growth 97
TABLE 30 CRYOABLATION EP CATHETERS MARKET, BY REGION,
2019–2027 (USD MILLION) 98
6.3.2 RADIOFREQUENCY (RF) ABLATION CATHETERS 98
6.3.2.1 Technological advancements in radiofrequency
ablation catheters to drive the market 98
TABLE 31 RF ABLATION CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION) 99
6.3.3 MICROWAVE ABLATION (MWA) SYSTEMS 99
6.3.3.1 Advantages of Microwave Ablation Systems over RF Ablation Catheters to drive market growth 99
TABLE 32 MWA SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION) 101
6.3.4 LASER ABLATION SYSTEMS 101
6.3.4.1 Technologically advanced products to drive market growth 101
TABLE 33 LASER ABLATION SYSTEMS MARKET, BY REGION,
2019–2027 (USD MILLION) 102
6.4 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 102
TABLE 34 EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 102
TABLE 35 EP DIAGNOSTIC CATHETERS MARKET, BY INDICATION,
2019–2027 (USD MILLION) 103
TABLE 36 EP DIAGNOSTIC CATHETERS MARKET, BY END USER,
2019–2027 (USD MILLION) 103
TABLE 37 EP DIAGNOSTIC CATHETERS MARKET, BY REGION,
2019–2027 (USD MILLION) 104
6.4.1 CONVENTIONAL ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 104
6.4.1.1 Increasing demand in emerging markets to support market growth 104
TABLE 38 CONVENTIONAL EP DIAGNOSTIC CATHETERS MARKET, BY REGION,
2019–2027 (USD MILLION) 105
6.4.2 ADVANCED ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 105
6.4.2.1 Advantages of Advanced Electrophysiology Diagnostic Catheters over conventional EP diagnostic catheters to drive market growth 105
TABLE 39 ADVANCED EP DIAGNOSTIC CATHETERS MARKET, BY REGION,
2019–2027 (USD MILLION) 106
6.4.3 ULTRASOUND ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 106
6.4.3.1 Increased demand due to rising use of ICE ultrasound imaging systems to drive market growth 106
TABLE 40 ULTRASOUND EP DIAGNOSTIC CATHETERS MARKET,
BY REGION, 2019–2027 (USD MILLION) 107
6.5 ACCESS DEVICES 107
6.5.1 LAUNCH OF TECHNOLOGICALLY ADVANCED PRODUCTS
TO DRIVE MARKET GROWTH 107
TABLE 41 ACCESS DEVICES MARKET, BY INDICATION, 2019–2027 (USD MILLION) 108
TABLE 42 ACCESS DEVICES MARKET, BY END USER, 2019–2027 (USD MILLION) 108
TABLE 43 ACCESS DEVICES MARKET, BY REGION, 2019–2027 (USD MILLION) 109
6.6 OTHER PRODUCTS 109
TABLE 44 OTHER PRODUCTS MARKET, BY INDICATION, 2019–2027 (USD MILLION) 109
TABLE 45 OTHER PRODUCTS MARKET, BY END USER, 2019–2027 (USD MILLION) 110
TABLE 46 OTHER PRODUCTS MARKET, BY REGION, 2019–2027 (USD MILLION) 110
7 ELECTROPHYSIOLOGY MARKET, BY INDICATION TYPE 111
7.1 INTRODUCTION 112
TABLE 47 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019–2027 (USD MILLION) 112
7.2 ATRIAL FIBRILLATION 112
7.2.1 GROWING INITIATIVES TO SHOWCASE ADVANTAGES OF CATHETER ABLATION OVER ANTIARRHYTHMIC DRUGS TO DRIVE MARKET GROWTH 112
TABLE 48 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FIBRILLATION, BY REGION, 2019–2027 (USD MILLION) 113
7.3 ATRIAL FLUTTER 114
7.3.1 HIGH SUCCESS RATE OF RADIOFREQUENCY CATHETER ABLATION FOR TREATMENT OF ATRIAL FLUTTER TO DRIVE MARKET GROWTH 114
TABLE 49 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FLUTTER, BY REGION,
2019–2027 (USD MILLION) 114
7.4 ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT) 115
7.4.1 INCREASING VALIDATION OF EFFICACY OF ELECTROPHYSIOLOGY DEVICES FOR AVNRT TO DRIVE MARKET GROWTH 115
TABLE 50 ELECTROPHYSIOLOGY MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA, BY REGION, 2019–2027 (USD MILLION) 115
7.5 WOLFF-PARKINSON-WHITE SYNDROME (WPW) 116
7.5.1 PREFERENCE FOR RADIOFREQUENCY ABLATION OVER SURGERY TO TREAT WOLFF-PARKINSON-WHITE SYNDROME TO DRIVE MARKET GROWTH 116
TABLE 51 ELECTROPHYSIOLOGY MARKET FOR WOLFF-PARKINSON-WHITE SYNDROME, BY REGION, 2019–2027 (USD MILLION) 116
7.6 OTHER INDICATIONS 117
TABLE 52 ELECTROPHYSIOLOGY MARKET FOR OTHER INDICATIONS, BY REGION, 2019–2027 (USD MILLION) 117

8 ELECTROPHYSIOLOGY MARKET, BY END USER 118
8.1 INTRODUCTION 119
TABLE 53 ELECTROPHYSIOLOGY MARKET, BY END USER, 2019–2027 (USD MILLION) 119
8.2 HOSPITALS & CARDIAC CENTERS 119
8.2.1 HOSPITAL & CARDIAC CENTERS TO DOMINATE END USER SEGMENT 119
TABLE 54 ELECTROPHYSIOLOGY MARKET FOR HOSPITALS & CARDIAC CENTERS,
BY REGION, 2019–2027 (USD MILLION) 120
8.3 AMBULATORY SURGERY CENTERS 120
8.3.1 INCREASING NUMBER OF AMBULATORY SURGICAL CENTERS IN THE US TO DRIVE ADOPTION OF ELECTROPHYSIOLOGY DEVICES 120
TABLE 55 ELECTROPHYSIOLOGY MARKET FOR AMBULATORY SURGERY CENTERS,
BY REGION, 2019–2027 (USD MILLION) 121
9 ELECTROPHYSIOLOGY MARKET, BY REGION 122
9.1 INTRODUCTION 123
FIGURE 24 GEOGRAPHIC SNAPSHOT OF ELECTROPHYSIOLOGY MARKET 123
TABLE 56 ELECTROPHYSIOLOGY MARKET, BY REGION, 2019–2027 (USD MILLION) 124
9.2 NORTH AMERICA 125
FIGURE 25 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET SNAPSHOT 125
TABLE 57 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY,
2019–2027 (USD MILLION) 126
TABLE 58 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 126
TABLE 59 NORTH AMERICA: EP LABORATORY DEVICES MARKET, BY TYPE,
2019–2027 (USD MILLION) 127
TABLE 60 NORTH AMERICA: EP ABLATION CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 127
TABLE 61 NORTH AMERICA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 128
TABLE 62 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2019–2027 (USD MILLION) 128
TABLE 63 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER,
2019–2027 (USD MILLION) 129
9.2.1 US 129
9.2.1.1 Technological advancements to drive market growth 129
TABLE 64 CLINICAL TRIALS RELATED TO ELECTROPHYSIOLOGY DEVICES 130
TABLE 65 US: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 131
TABLE 66 US: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 131
TABLE 67 US: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 132
TABLE 68 US: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 132
9.2.2 CANADA 133
9.2.2.1 Growing government funding for research to support market growth 133
TABLE 69 RESEARCH GRANTS TOWARDS RESEARCH IN CARDIOLOGY 134
TABLE 70 CANADA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 135
TABLE 71 CANADA: EP LABORATORY DEVICES MARKET, BY TYPE,
2019–2027 (USD MILLION) 135
TABLE 72 CANADA: EP ABLATION CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 136
TABLE 73 CANADA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 136
9.3 EUROPE 137
TABLE 74 EUROPE: ELECTROPHYSIOLOGY MARKET, BY COUNTRY,
2019–2027 (USD MILLION) 137
TABLE 75 EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 138
TABLE 76 EUROPE: EP LABORATORY DEVICES MARKET, BY TYPE,
2019–2027 (USD MILLION) 138
TABLE 77 EUROPE: EP ABLATION CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 139
TABLE 78 EUROPE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 139
TABLE 79 EUROPE: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2019–2027 (USD MILLION) 140
TABLE 80 EUROPE: ELECTROPHYSIOLOGY MARKET, BY END USER,
2019–2027 (USD MILLION) 140
9.3.1 GERMANY 141
9.3.1.1 Rising healthcare expenditure and growing use of electrophysiology devices to drive market growth 141
TABLE 81 GERMANY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 141
TABLE 82 GERMANY: EP LABORATORY DEVICES MARKET, BY TYPE,
2019–2027 (USD MILLION) 142
TABLE 83 GERMANY: EP ABLATION CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 142
TABLE 84 GERMANY: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 143
9.3.2 UK 143
9.3.2.1 Growing geriatric population to drive market growth 143
TABLE 85 UK: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 144
TABLE 86 UK: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 144
TABLE 87 UK: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 145
TABLE 88 UK: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 145
9.3.3 FRANCE 146
9.3.3.1 Increasing incidence of heart failure to support market growth 146
TABLE 89 FRANCE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 146
TABLE 90 FRANCE: EP LABORATORY DEVICES MARKET, BY TYPE,
2019–2027 (USD MILLION) 147
TABLE 91 FRANCE: EP ABLATION CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 147
TABLE 92 FRANCE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 148
9.3.4 ITALY 148
9.3.4.1 Rising incidence of CVDs to drive electrophysiology devices adoption 148
TABLE 93 ITALY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 149
TABLE 94 ITALY: EP LABORATORY DEVICES MARKET, BY TYPE,
2019–2027 (USD MILLION) 149
TABLE 95 ITALY: EP ABLATION CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 150
TABLE 96 ITALY: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 150
9.3.5 SPAIN 151
9.3.5.1 Growing number of cardiac ablation procedures
to drive market growth 151
TABLE 97 SPAIN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 151
TABLE 98 SPAIN: EP LABORATORY DEVICES MARKET, BY TYPE,
2019–2027 (USD MILLION) 152
TABLE 99 SPAIN: EP ABLATION CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 152
TABLE 100 SPAIN: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 153
9.3.6 REST OF EUROPE 153
TABLE 101 CARDIAC AF ABLATION PROCEDURES, BY COUNTRY, 2015 VS. 2016 154
TABLE 102 ROE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 154
TABLE 103 ROE: EP LABORATORY DEVICES MARKET, BY TYPE,
2019–2027 (USD MILLION) 155
TABLE 104 ROE: EP ABLATION CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 155
TABLE 105 ROE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 156
9.4 ASIA PACIFIC 156
FIGURE 26 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET SNAPSHOT 157
TABLE 106 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY COUNTRY,
2019–2027 (USD MILLION) 158
TABLE 107 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 158
TABLE 108 ASIA PACIFIC: EP LABORATORY DEVICES MARKET, BY TYPE,
2019–2027 (USD MILLION) 159
TABLE 109 ASIA PACIFIC: EP ABLATION CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 159
TABLE 110 ASIA PACIFIC: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 160
TABLE 111 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2019–2027 (USD MILLION) 160
TABLE 112 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY END USER,
2019–2027 (USD MILLION) 161
9.4.1 JAPAN 161
9.4.1.1 Favorable reimbursement scenario to support market growth 161
TABLE 113 JAPAN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 162
TABLE 114 JAPAN: EP LABORATORY DEVICES MARKET, BY TYPE,
2019–2027 (USD MILLION) 162
TABLE 115 JAPAN: EP ABLATION CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 163
TABLE 116 JAPAN: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 163
9.4.2 CHINA 164
9.4.2.1 Growing geriatric population to drive market growth 164
TABLE 117 CHINA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 164
TABLE 118 CHINA: EP LABORATORY DEVICES MARKET, BY TYPE,
2019–2027 (USD MILLION) 165
TABLE 119 CHINA: EP ABLATION CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 165
TABLE 120 CHINA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 166
9.4.3 INDIA 166
9.4.3.1 Increasing healthcare initiatives by government to drive market growth 166
TABLE 121 INDIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 167
TABLE 122 INDIA: EP LABORATORY DEVICES MARKET, BY TYPE,
2019–2027 (USD MILLION) 167
TABLE 123 INDIA: EP ABLATION CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 168
TABLE 124 INDIA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 168
9.4.4 AUSTRALIA 169
9.4.4.1 Increasing target disease burden to support market growth 169
TABLE 125 AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 169
TABLE 126 AUSTRALIA: EP LABORATORY DEVICES MARKET, BY TYPE,
2019–2027 (USD MILLION) 170
TABLE 127 AUSTRALIA: EP ABLATION CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 170
TABLE 128 AUSTRALIA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 171
9.4.5 SOUTH KOREA 171
9.4.5.1 Supportive government initiatives to drive market growth 171
TABLE 129 SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 172
TABLE 130 SOUTH KOREA: EP LABORATORY DEVICES MARKET, BY TYPE,
2019–2027 (USD MILLION) 172
TABLE 131 SOUTH KOREA: EP ABLATION CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 173
TABLE 132 SOUTH KOREA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 173
9.4.6 REST OF ASIA PACIFIC 173
TABLE 133 ROAPAC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 174
TABLE 134 ROAPAC: EP LABORATORY DEVICES MARKET, BY TYPE,
2019–2027 (USD MILLION) 175
TABLE 135 ROAPAC: EP ABLATION CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 175
TABLE 136 ROAPAC: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 176
9.5 LATIN AMERICA 176
TABLE 137 LATAM: ELECTROPHYSIOLOGY MARKET, BY COUNTRY,
2019–2027 (USD MILLION) 177
TABLE 138 LATAM: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 177
TABLE 139 LATAM: EP LABORATORY DEVICES MARKET, BY TYPE,
2019–2027 (USD MILLION) 178
TABLE 140 LATAM: EP ABLATION CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 178
TABLE 141 LATAM: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 179
TABLE 142 LATAM: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2019–2027 (USD MILLION) 179
TABLE 143 LATAM: ELECTROPHYSIOLOGY MARKET, BY END USER,
2019–2027 (USD MILLION) 180
9.5.1 BRAZIL 180
9.5.1.1 Modernization of healthcare facilities to drive market growth 180
TABLE 144 BRAZIL: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 181
TABLE 145 BRAZIL: EP LABORATORY DEVICES MARKET, BY TYPE,
2019–2027 (USD MILLION) 181
TABLE 146 BRAZIL: EP ABLATION CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 182
TABLE 147 BRAZIL: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 182
9.5.2 MEXICO 183
9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth 183
TABLE 148 MEXICO: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 183
TABLE 149 MEXICO: EP LABORATORY DEVICES MARKET, BY TYPE,
2019–2027 (USD MILLION) 184
TABLE 150 MEXICO: EP ABLATION CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 184
TABLE 151 MEXICO: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 185
9.5.3 REST OF LATIN AMERICA 185
TABLE 152 ROLA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 185
TABLE 153 ROLA: EP LABORATORY DEVICES MARKET, BY TYPE,
2019–2027 (USD MILLION) 186
TABLE 154 ROLA: EP ABLATION CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 186
TABLE 155 ROLA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 187
9.6 MIDDLE EAST & AFRICA 187
TABLE 156 MEA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 188
TABLE 157 MEA: EP LABORATORY DEVICES MARKET, BY TYPE,
2019–2027 (USD MILLION) 188
TABLE 158 MEA: EP ABLATION CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 189
TABLE 159 MEA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2019–2027 (USD MILLION) 189
TABLE 160 MEA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2019–2027 (USD MILLION) 190
TABLE 161 MEA: ELECTROPHYSIOLOGY MARKET, BY END USER,
2019–2027 (USD MILLION) 190
10 COMPETITIVE LANDSCAPE 191
10.1 INTRODUCTION 191
FIGURE 27 KEY DEVELOPMENTS BY LEADING PLAYERS IN
ELECTROPHYSIOLOGY MARKET, 2018–2021 191
10.2 REVENUE SHARE ANALYSIS 192
FIGURE 28 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN
ELECTROPHYSIOLOGY MARKET 192
10.3 MARKET SHARE ANALYSIS 193
FIGURE 29 ELECTROPHYSIOLOGY MARKET SHARE, BY KEY PLAYER, 2020 193
TABLE 162 ELECTROPHYSIOLOGY MARKET: DEGREE OF COMPETITION 193
10.4 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2020) 195
10.4.1 STARS 195
10.4.2 EMERGING LEADERS 195
10.4.3 PERVASIVE PLAYERS 195
10.4.4 PARTICIPANTS 195
FIGURE 30 ELECTROPHYSIOLOGY MARKET: COMPETITIVE LEADERSHIP MAPPING (2020) 196

10.5 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT
(AS OF 2020) 197
10.5.1 PROGRESSIVE COMPANIES 197
10.5.2 RESPONSIVE COMPANIES 197
10.5.3 DYNAMIC COMPANIES 197
10.5.4 STARTING BLOCKS 197
FIGURE 31 ELECTROPHYSIOLOGY MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS) (2020) 198
10.6 COMPETITIVE BENCHMARKING 199
TABLE 163 PRODUCT FOOTPRINT ANALYSIS OF TOP PLAYERS IN ELECTROPHYSIOLOGY MARKET 199
TABLE 164 COMPANY FOOTPRINT ANALYSIS IN ELECTROPHYSIOLOGY MARKET 200
10.7 COMPETITIVE SCENARIO (2018–2021) 201
10.7.1 PRODUCT LAUNCHES 201
10.7.2 APPROVALS 202
10.7.3 DEALS 204
11 COMPANY PROFILES 208
11.1 KEY PLAYERS 208
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 ABBOTT 208
TABLE 165 ABBOTT: BUSINESS OVERVIEW 208
FIGURE 32 ABBOTT: COMPANY SNAPSHOT (2020) 209
11.1.2 MEDTRONIC 214
TABLE 166 MEDTRONIC: BUSINESS OVERVIEW 214
FIGURE 33 MEDTRONIC: COMPANY SNAPSHOT (2021) 215
11.1.3 BOSTON SCIENTIFIC CORPORATION 220
TABLE 167 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 220
FIGURE 34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020) 221
11.1.4 KONINKLIJKE PHILIPS N.V. 227
TABLE 168 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 227
FIGURE 35 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020) 228
11.1.5 GE HEALTHCARE 231
TABLE 169 GE HEALTHCARE: BUSINESS OVERVIEW 231
FIGURE 36 GE HEALTHCARE: COMPANY SNAPSHOT (2020) 232
11.1.6 SIEMENS HEALTHINEERS 234
TABLE 170 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW 234
FIGURE 37 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2020) 235
11.1.7 STEREOTAXIS, INC. 237
TABLE 171 STEREOTAXIS, INC.: BUSINESS OVERVIEW 237
FIGURE 38 STEREOTAXIS: COMPANY SNAPSHOT (2020) 238
11.1.8 MERIT MEDICAL SYSTEMS 241
TABLE 172 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW 241
FIGURE 39 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2020) 242
11.1.9 ATRICURE INC. 243
TABLE 173 ATRICURE, INC.: BUSINESS OVERVIEW 243
FIGURE 40 ATRICURE, INC.: COMPANY SNAPSHOT (2020) 244
11.1.10 APN HEALTH, LLC 246
TABLE 174 APN HEALTH, LLC: BUSINESS OVERVIEW 246
11.1.11 OSYPKA MEDICAL 247
TABLE 175 OSYPKA MEDICAL: BUSINESS OVERVIEW 247
11.1.12 JAPAN LIFELINE CO., LTD. 249
TABLE 176 JAPAN LIFELINE CO., LTD.: BUSINESS OVERVIEW 249
FIGURE 41 JAPAN LIFELINE CO., LTD.: COMPANY SNAPSHOT (2020) 249
11.1.13 JOHNSON & JOHNSON 251
TABLE 177 JOHNSON & JOHNSON: BUSINESS OVERVIEW 251
FIGURE 42 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020) 252
11.1.14 BIOTRONIK 258
TABLE 178 BIOTRONIK: BUSINESS OVERVIEW 258
11.1.15 MICROPORT SCIENTIFIC CORPORATION 262
TABLE 179 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 262
FIGURE 43 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020) 263
11.1.16 ACUTUS MEDICAL, INC. 265
TABLE 180 ACUTUS MEDICAL, INC.: BUSINESS OVERVIEW 265
FIGURE 44 ACUTUS MEDICAL INC.: COMPANY SNAPSHOT (2020) 266
11.2 OTHER PLAYERS 269
11.2.1 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 269
11.2.2 CATHRX LTD. 270
11.2.3 COOK MEDICAL 271
11.2.4 CATHVISION APS 272
11.2.5 TZ MEDICAL 273
11.2.6 TELEFLEX INCORPORATED 274
11.2.7 IMRICOR 275
11.2.8 CARDIOFOCUS 276
11.2.9 SCHWARZER CARDIOTEK GMBH 277
11.2.10 KARDIUM 278
11.2.11 EP SOLUTIONS SA 279
11.2.12 BIOSIG TECHNOLOGIES, INC. (BSGM) 280
11.2.13 COREMAP 281
11.2.14 EPMAP SYSTEM GMBH 282
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX 283
12.1 DISCUSSION GUIDE 283
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 288
12.3 AVAILABLE CUSTOMIZATIONS 290
12.4 RELATED REPORTS 290
12.5 AUTHOR DETAILS 291

ページTOPに戻る

Table of Contents

Summary

The global electrophysiology market is projected to reach USD 11.6 billion by 2027 from USD 6.8 billion in 2021, at a CAGR of 9.4% during the forecast period of 2022 to 2027.

An electrophysiology (EP) test is conducted to study the electrical activities and electrical pathways of the patient’s heart to diagnose and treat complex cardiac diseases. It enables electrophysiologists to understand the cause of heart rhythm disturbances and suggest the required treatment. Electrophysiology (EP) is defined as the heart’s electrical system that is being studied to analyze and diagnose its electrical activities. Cardiac electrophysiology studies the phenomena by recording the electrical activities of the heart using an invasive catheter. This study helps in assessing complex Arrhythmias or heart rhythm disorders.

The growth of the global electrophysiology market can be attributed to factors such as technological advancements; new entrants in the market; growing investments, funds, and grants; and an increased incidence of target diseases and procedures. Emerging markets are also expected to offer high growth opportunities for players operating in this market.

According to the WHO, CVD is the leading cause of death around the world. Major factors contributing to the rising prevalence of CVD and strokes include family history, ethnicity, and age. According to the American Heart Association, by 2030, about 41.4% of the US adults will have hypertension (an increase of 8.4% from 2012). The organization also estimates that the global cost of CVD will reach USD 1,044 billion by 2030 from USD 863 billion in 2010. In 2016, ~17.9 million people died of CVD worldwide. It is estimated that, by 2030, this number will increase to 23.6 million (Source: WHO).

AF is the most common arrhythmia diagnosed in clinical practices, affecting over 886,000 new people each year in Europe. By 2030, the number of people with AF is expected to increase by up to 70% of the population; by 2050, Europe is expected to have the highest number of patients with AF (Source: 2018 Report on Burden of Atrial Fibrillation). In the US, AF affected between about 2.7 million to 6.1 million people in 2012; this is estimated to rise to 12.1 million by 2030 (Source: CDC). According to a study published in the Medical Journal of Australia in August 2015, the number of AF patients aged above 55 years in Australia was 328,562 in June 2014 and is estimated to reach over 600,000 cases by 2034. The rising incidence of these diseases will correspondingly drive the demand for EP procedures, which makes it a primary growth driver for the electrophysiology market. For instance, the global ablation procedure numbers are predicted to grow from 973,220 in 2017 to 1,455,000 per year by 2022; within this category, complex ablations (AF and VT) is expected to increase by 13.5% annually from 440,629 in 2017 to 830,390 in 2022 (Source: BioSig Technologies, Annual Report, 2019).

However, factors such as the high cost of electrophysiology products, inadequate reimbursement, unfavorable healthcare reforms in the US, cost-intensive requirement for clinical data for new product launches, and the availability of alternative technologies are expected to restrain the growth of this market in the coming years. The reuse & reprocessing of devices and lack of skilled and experienced electrophysiologists are some of the challenges in this market. The growth of the market is also expected to slow temporarily during the forecast period due to the COVID-19 pandemic.

“Electrophysiology Laboratory Device segment accounted for the largest share of global electrophysiology market in 2021”

On the basis of product, the global electrophysiology market is broadly classified into EP diagnostic catheters, EP ablation catheters, EP laboratory devices, access devices, and other products.

EP laboratory devices market is segmented into 3D mapping systems, EP recording systems, RF ablation systems, intra-cardiac echocardiography (ICE) ultrasound imaging systems, EP X-ray systems, and other electrophysiology laboratory devices (MRI systems and EP remote magnetic and robotic navigation systems).
The EP laboratory devices segment commanded the largest share of 57.0% of the electrophysiology market in 2021. This segment is estimated to grow at a CAGR of 10.6% during the forecast period.

The large share of this segment can be attributed to the increasing focus of market players on the launch of technologically advanced 3D mapping systems, increasing public-private funding for the development of novel electrophysiology recording systems, the rising number of RF ablation procedures, the cost-effectiveness of RF ablation procedures as compared to other ablation techniques, and increasing availability of these products in major markets.

“Hospitals and cardiac centres segment accounted for the largest market share of the electrophysiology market based on end user in 2021”

On the basis of the end user segment, the electrophysiology market is segmented into hospitals & cardiac centers and ambulatory surgery centers. The hospitals & cardiac centers segment holds the largest share of the market (92.53%) in 2021. The large share of this end user segment can primarily be attributed to the presence of big cath labs and electrophysiology labs in hospitals, a rising prevalence of CVDs, and an increased number of ablation procedures.

The hospital & cardiac centers segment includes both government & private hospitals and cardiac centers that provide treatment to patients with cardiac diseases. Almost all electrophysiology procedures are carried out in the electrophysiology (EP) laboratory or catheterization laboratory (cath lab) of hospitals or cardiac centers. The number of cardiac centers providing treatment to patients with heart conditions is growing rapidly across the world. For instance, in June 2016, Health Sciences North (Canada) and a team of cardiologists in Greater Sudbury (Canada) joined forces to launch a new one-stop center for cardiac care. In October 2016, US-based Kare Partners Group launched a specialized heart care center in Chandigarh, India. Such launches are expected to drive the demand for electrophysiology devices.

“Atrial Fibrillation segment accounted for the largest market share of the electrophysiology market based on indication type in 2021”

On the basis of indication type, the electrophysiology market is segmented into atrial fibrillation, atrioventricular nodal reentry tachycardia (AVNRT), Wolff-Parkinson-White (WPW) syndrome, atrial flutter, and other indications. The increasing prevalence of atrial fibrillation, the growing number of ablation procedures related to atrial fibrillation, rapid growth in the aging population globally, and the development of advanced electrophysiology products for the early diagnosis of atrial fibrillation are expected to drive the growth of this market segment in the coming years.

The atrial fibrillation market accounted for the largest share of the electrophysiology market, by indication, in 2021. The atrial flutter segment is estimated to account for the second-largest share of the global electrophysiology market in 2021.

About 5.3 million people in the US were reportedly suffering from atrial fibrillation in 2019 (Source: American Heart Association). By 2050, atrial fibrillation is expected to affect approximately 12 million people in the US. According to the paper published in EP Europace, a journal of the European Society of Cardiology (ESC), around 7.6 million people over 65 in the EU region had atrial fibrillation in 2016, and this will increase by 89% to 14.4 million by 2060. This growth in the prevalence of atrial fibrillation is expected to result in a significant increase in the number of atrial fibrillation ablation procedures conducted.

Owing to the increasing prevalence of AFib, many key players are undertaking studies to showcase the advantages of catheter ablation over antiarrhythmic drugs (AADs). For instance, in November 2019, Biosense Webster released a new Atrial Fibrillation Management Report, which highlights that catheter ablation is almost ten times more effective at delaying Atrial Fibrillation progression than drug therapy.

“The APAC market, by region, to register highest growth rate in the forecast period”

On the basis of region, the Electrophysiology market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to register the highest growth during the forecast period. The Asia Pacific is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific, including Malaysia, Taiwan, Singapore, and New Zealand.

China and India are expected to account for the highest growth rate. Changing lifestyles and eating habits, increasing stress, and rising habitual smoking & drinking in these countries have resulted in growing health-related problems such as obesity, heart disease, and other chronic diseases. Factors such as large population, increasing geriatric population, the growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, increasing demand for advanced technologies, the growing emphasis of prominent players on emerging markets, and less stringent regulations are also fueling the demand for electrophysiology devices in this region.

However, the high cost of advanced products, inadequate infrastructural capabilities to comply with the latest cardiac resynchronization technologies, and a lack of awareness about health-related issues are expected to hamper the growth of this market. Many end users in this regional segment have controlled budgets and opt for low-cost products, which is another major factor limiting the market growth.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–25%, Tier 2–37%, and Tier 3– 38%
• By Designation: C-level–34%, Director-level–35%, and Others–31%
• By Region: North America–24%, Europe–32%, Asia Pacific–28%, Latin America–10%, and the Middle East & Africa–6%

Prominent players in the electrophysiology market include Abbott (US), Medtronic (Ireland), Boston Scientific Corporation (US), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Siemens Healthcare GmbH (Germany), Stereotaxis, Inc. (US), Merit Medical Systems (US), Atricure Inc. (US), APN Health, LLC (US), Osypka Medical (Germany), Japan LifeLine Co., Ltd. (Japan), Johnson & Johnson (US), Biotronik (Germany), MicroPort Scientific Corporation (China), and Acutus Medical, Inc. (US).

Research Coverage

This report studies the electrophysiology market based on product type, indication type, end user and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:
 Market Penetration: Comprehensive information on the product portfolios offered by the top players in the electrophysiology market
 Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the electrophysiology market
 Market Development: Comprehensive information on lucrative emerging regions
 Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the electrophysiology market
 Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（ソフトウェア）の最新刊レポート

MarketsandMarkets社のその他分野での最新刊レポート

本レポートと同じKEY WORD（devices）の最新刊レポート

患者モニタリングデバイス市場：製品別（EEG、MEG、TCD、パルスオキシメーター、スパイロメーター、胎児モニター、体温モニター、MCOT、ECG、ICP、ILR、マルチパラメーターモニター、体重モニタリング）、エンドユーザー別（病院、ASC） - 2027年までの世界市場予測

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（ソフトウェア）の最新刊レポート

MarketsandMarkets社のその他分野での最新刊レポート

本レポートと同じKEY WORD（devices）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?